Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA (MEI-005)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01993641
Recruitment Status : Completed
First Posted : November 25, 2013
Last Update Posted : February 23, 2017
Sponsor:
Information provided by (Responsible Party):
Helsinn Healthcare SA

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2015
Actual Study Completion Date : June 2016
Certification/Extension First Submitted : September 12, 2016